Nicotine dependence - human and animal studies, current pharmacotherapies and future perspectives.
Journal Title: Pharmacological Reports - Year 2009, Vol 61, Issue 6
Abstract
Nicotine dependence is a disease of constantly growing importance. This mini-review describes the effects of nicotine in humans and focuses on the various laboratory animal models developed to study the dependence-related behavioral effects of nicotine. In addition, we outline the current therapeutic approaches designed to substitute nicotine from cigarette smoke with safer compounds or to relieve symptoms of nicotine withdrawal during smoking abstinence. Since several pharmacotherapies have failed to be efficacious in all patients, we also assess the clinical effectiveness of newer agents in relation to existing drugs.
Authors and Affiliations
Magdalena Zaniewska, Edmund Przegaliński, Małgorzata Filip
Keywords
Related Articles
- EP ID EP113234
- DOI -
- Views 120
- Downloads 0
Role of nitric oxide in the development of tolerance to diazepam-induced motor impairment in mice.
Chronic treatment with the benzodiazepines is well known to produce tolerance, which has been extensively documented to be attributed to modifications in the gamma-aminobutyric acid (GABA)ergic neurotransmission. However...
Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system.
The present review gives an overview on the serotonin (5-hydroxytryptamine; 5-HT) system, its receptors and their relationship to central nervous system physiology and disorders. Additionally, we also introduce the recen...
Lack of effect of naltrexone on the spinal synergism between morphine and non steroidal anti-inflammatory drugs.
To enhance analgesia, the combinatorial use of analgesic drugs with proven efficacies is a widely-used strategy to reduce adverse side effects. The present study characterizes the antinociceptive interaction of intrathec...
Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats.
It has been recognized that the stress-related peptides are involved in anxiety states. Angiotensin II receptor blockade by systemic administration of the AT(1) receptor antagonists has been proposed as a new treatment p...
Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells.
Background: Dihydroartemisinin (DHA) exhibits potent anti-malarial and anti-cancer activities. This study aimed to investigate the anti-proliferative effects of a combination of DHA and doxorubicin (DOX) on human breast...